$1.05 Billion is the total value of RTW INVESTMENTS, LP's 38 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 68.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RCKT | New | Rocket Pharmaceuticals Inc | $258,228,000 | – | 14,969,744 | +100.0% | 24.58% | – |
| PTCT | Buy | PTC Therapeutics Inc | $111,973,000 | +62.5% | 4,137,960 | +0.2% | 10.66% | -7.3% |
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $69,346,000 | +34.8% | 1,096,386 | +30.6% | 6.60% | -23.1% |
| RGNX | Buy | Regenxbio Inc | $56,051,000 | +8.0% | 1,877,767 | +20.3% | 5.33% | -38.4% |
| SRPT | New | Sarepta Therapeutics Inc | $50,994,000 | – | 688,271 | +100.0% | 4.85% | – |
| ACHN | Sell | ACHILLION PHARMACEUTICALS IN | $50,074,000 | +28.3% | 13,496,902 | -0.4% | 4.76% | -26.8% |
| DRNA | Sell | Dicerna Pharmaceuticals Inc | $48,082,000 | +8.9% | 5,029,462 | -0.1% | 4.58% | -37.9% |
| AGEN | Buy | Agenus Inc | $43,867,000 | +210.8% | 9,313,556 | +115.1% | 4.18% | +77.2% |
| LJPC | Buy | La Jolla Pharmaceutical Co | $33,429,000 | -2.3% | 1,122,540 | +5.6% | 3.18% | -44.3% |
| ALNY | Sell | Alnylam Pharmaceuticals Inc | $29,326,000 | -35.7% | 246,229 | -31.4% | 2.79% | -63.3% |
| AVXS | Sell | Avexis Inc | $29,217,000 | -6.1% | 236,425 | -15.9% | 2.78% | -46.5% |
| ABUS | Arbutus Biopharma Corp | $25,758,000 | -1.0% | 5,151,615 | 0.0% | 2.45% | -43.6% | |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $22,069,000 | -6.8% | 456,921 | -24.1% | 2.10% | -46.9% |
| CORI | Buy | CORIUM INTL INC | $21,914,000 | +34.2% | 1,910,522 | +12.4% | 2.08% | -23.5% |
| ARWR | New | ARROWHEAD PHARMACEUTICALS IN | $21,028,000 | – | 2,916,561 | +100.0% | 2.00% | – |
| VCEL | Buy | Vericel Corp | $20,576,000 | +189.4% | 2,067,916 | +58.5% | 1.96% | +65.0% |
| MASI | Buy | Masimo Corp | $20,404,000 | +99.0% | 232,000 | +91.9% | 1.94% | +13.5% |
| EW | Buy | Edwards Lifesciences Corp | $20,265,000 | +46.2% | 145,246 | +18.1% | 1.93% | -16.6% |
| ARMO | New | Armo Biosciences Inc | $13,969,000 | – | 413,892 | +100.0% | 1.33% | – |
| MYOK | Buy | Myokardia Inc | $12,672,000 | +16.8% | 259,670 | +0.8% | 1.21% | -33.4% |
| LIVN | New | LivaNova PLC | $12,390,000 | – | 140,000 | +100.0% | 1.18% | – |
| QURE | Buy | Uniqure NV | $9,557,000 | +20.9% | 406,667 | +0.8% | 0.91% | -31.0% |
| VIVE | Buy | VIVEVE MED INC | $9,361,000 | +12.6% | 2,557,559 | +52.9% | 0.89% | -35.8% |
| VRAY | Buy | Viewray Inc | $8,737,000 | -30.0% | 1,358,711 | +0.8% | 0.83% | -60.1% |
| NVTRQ | New | Nuvectra Corp | $6,602,000 | – | 507,061 | +100.0% | 0.63% | – |
| BVX | Buy | Bovie Medical Corp | $5,738,000 | +25.9% | 1,931,948 | +10.2% | 0.55% | -28.3% |
| NVAX | New | Novavax Inc | $5,726,000 | – | 2,726,504 | +100.0% | 0.54% | – |
| ODT | Sell | Odonate Therapeutics Inc | $5,303,000 | -21.6% | 274,544 | -7.7% | 0.50% | -55.3% |
| PTI | Sell | PROTEOSTASIS THERAPEUTICS IN | $5,248,000 | -40.0% | 1,104,940 | -26.3% | 0.50% | -65.8% |
| SLDB | New | Solid Biosciences Inc | $4,612,000 | – | 675,771 | +100.0% | 0.44% | – |
| CDNA | New | CareDx Inc | $4,468,000 | – | 560,600 | +100.0% | 0.42% | – |
| FIXX | New | Homology Medicines Inc | $4,208,000 | – | 225,000 | +100.0% | 0.40% | – |
| New | VIVUS INCnote 4.500% 5/0 | $2,500,000 | – | 4,000,000 | +100.0% | 0.24% | – | |
| ARGX | Buy | ARGENX SEsponsored adr | $2,048,000 | +28.4% | 25,457 | +0.8% | 0.20% | -26.7% |
| OSUR | Sell | OraSure Technologies Inc | $1,981,000 | -88.0% | 117,291 | -86.6% | 0.19% | -93.2% |
| NVUS | New | Novus Therapeutics Inc | $1,512,000 | – | 300,000 | +100.0% | 0.14% | – |
| ADVM | New | Adverum Biotechnologies Inc | $1,016,000 | – | 175,208 | +100.0% | 0.10% | – |
| MOTS | New | MOTUS GI HLDGS INC | $531,000 | – | 118,478 | +100.0% | 0.05% | – |
| SRTSW | Exit | SENSUS HEATLHCARE INC*w exp 06/08/201 | $0 | – | -151,400 | -100.0% | -0.02% | – |
| RVNC | Exit | Revance Therapeutics Inc | $0 | – | -23,038 | -100.0% | -0.14% | – |
| FPRX | Exit | Five Prime Therapeutics Inc | $0 | – | -100,377 | -100.0% | -0.37% | – |
| ZYNE | Exit | Zynerba Pharmaceuticals Inc | $0 | – | -202,859 | -100.0% | -0.42% | – |
| OXFD | Exit | Oxford Immunotec Global PLC | $0 | – | -375,792 | -100.0% | -0.88% | – |
| TCMD | Exit | Tactile Systems Technology Inc | $0 | – | -210,366 | -100.0% | -1.02% | – |
| ATRA | Exit | Atara Biotherapeutics Inc | $0 | – | -556,118 | -100.0% | -1.68% | – |
| BCRX | Exit | BioCryst Pharmaceuticals Inc | $0 | – | -3,372,674 | -100.0% | -2.76% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS INC | 36 | Q3 2023 | 19.7% |
| MASIMO CORP | 32 | Q3 2023 | 5.8% |
| LA JOLLA PHARMACEUTICAL CO | 31 | Q2 2022 | 9.7% |
| REGENXBIO INC | 30 | Q4 2022 | 10.8% |
| AGENUS INC | 29 | Q2 2022 | 9.0% |
| PTC THERAPEUTICS INC | 28 | Q3 2023 | 12.8% |
| DICERNA PHARMACEUTICALS INC | 28 | Q3 2021 | 10.8% |
| MIRATI THERAPEUTICS INC | 26 | Q3 2023 | 6.2% |
| ARGENX SE | 26 | Q3 2023 | 5.3% |
| VERICEL CORP | 24 | Q3 2023 | 3.9% |
View RTW INVESTMENTS, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | September 19, 2023 | 18,188,457 | - |
| ALLURION TECHNOLOGIES, INC. | August 11, 2023 | 3,457,707 | 7.4% |
| Orchestra BioMed Holdings, Inc. | May 05, 2023 | 5,620,645 | 15.7% |
| Renovacor, Inc.Sold out | April 05, 2023 | 0 | - |
| Adverum Biotechnologies, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Aptevo Therapeutics Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ASLAN Pharmaceuticals LtdSold out | February 14, 2023 | 0 | 0.0% |
| Athira Pharma, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| BELLUS Health Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Clearside Biomedical, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
View RTW INVESTMENTS, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-03-01 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View RTW INVESTMENTS, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.